Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy

Sponsor
University of Foggia (Other)
Overall Status
Completed
CT.gov ID
NCT05987787
Collaborator
(none)
33
1
17.9
1.8

Study Details

Study Description

Brief Summary

Staple line reinforcement (SLR) has been suggested as a mean of reducing the risk of sleeve leakage or bleeding. The aim of this study is to analyze if the suture reinforcement can be used to reduce the leakage rate after sleeve gastrectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: laparoscopic sleeve gastrectomy without suture reinforcement
  • Procedure: laparoscopic sleeve gastrectomy with suture reinforcement

Study Design

Study Type:
Observational
Actual Enrollment :
33 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Staple-line Suture Reinforcement: Could it Help Contain the Leak?
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Dec 31, 2022
Actual Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Obese patients underwent laparoscopic sleeve gastrectomy with suture reinforcement

Laparoscopic sleeve gastrectomy running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.

Procedure: laparoscopic sleeve gastrectomy with suture reinforcement
The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access. At this point, it is applied running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.

Obese patients underwent laparoscopic sleeve gastrectomy without suture reinforcement

Laparoscopic sleeve gastrectomy without staple line reinforcement.

Procedure: laparoscopic sleeve gastrectomy without suture reinforcement
The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access.

Outcome Measures

Primary Outcome Measures

  1. the importance of staple line reinforcement [1 year]

    reduction of the leak rate in the suture group

  2. the importance of staple line reinforcement [During Surgery]

    the differences of operative time between two groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • BMI>40 kg/m2

  • BMI>35 kg/m2with at least one associated major comorbidity

Exclusion Criteria:
  • secondary obesity due to endocrine and psychological disorders

  • patients under antiaggregant and anticoagulant therapy

  • re-do surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Foggia Foggia Italy 71122

Sponsors and Collaborators

  • University of Foggia

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Giovanna Pavone, Medical doctor, University of Foggia
ClinicalTrials.gov Identifier:
NCT05987787
Other Study ID Numbers:
  • 8
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 14, 2023